中风与神经疾病杂志2024，Vol.41Issue(7)：668-672,5.DOI:10.19845/j.cnki.zfysjjbzz.2024.0129
PCSK9抑制剂在缺血性脑卒中的研究进展
Research advances in PCSK9 inhibitors in ischemic stroke
周正交 1周芝文2
作者信息
- 1. 湖南师范大学临床医学院,湖南 长沙 410013
- 2. 湖南省人民医院(湖南师范大学附属第一医院),湖南 长沙 410013
- 折叠
摘要
Abstract
PCSK9 inhibitors are a new type of drug used to reduce the level of low-density lipoprotein cholesterol.In recent years,PCSK9 inhibitors have exhibited certain potential in the treatment of ischemic stroke;however,the research in ischemic stroke is still in its early stages,and further studies are needed to confirm the safety and efficacy of PCSK9 in-hibitors.This article summarizes the mechanism of action of PCSK9 inhibitors in ischemic stroke in recent years and ana-lyzes their potential for future application.关键词
PCSK9/PCSK9抑制剂/缺血性脑卒中/动脉粥样硬化Key words
PCSK9/PCSK9 inhibitor/Ischemic stroke/Atherosclerosis分类
医药卫生引用本文复制引用
周正交,周芝文..PCSK9抑制剂在缺血性脑卒中的研究进展[J].中风与神经疾病杂志,2024,41(7):668-672,5.
